Minutes of EGM
Glenmark Pharmaceuticals Ltd has submitted to BSE a copy of Minutes of Extra Ordinary General Meeting of the Company held on January 25, 2016.11-02-2016
11-02-2016
Glenmark introduces EMI scheme for cancer treatment drugs
Abirapro prescribed for prostate cancer and Evermil, indicated for different cancers, such as breast and renal cell carcinoma, are included under the scheme07-02-2016
Glenmark shares surge 3.4% on rating upgrade
Shares of Glenmark Pharmaceuticals today rallied over 3 per cent on HSBC rating.The stock jumped as much as 3.4 per cent as HSBC has upgraded the stock to buy from hold.The company has reported ...01-02-2016
Glenmark expects big growth from US: Glenn Saldanha
In an e-mail interview, Glenmark chairman says company has stopped supplies to Venezuela30-01-2016
Glenmark Q3 profit up 48% to Rs170.3 crore
Glenmark revenue increases 4.53% to `1,778.2 crore from `1,701 crore a year ago28-01-2016
Cancellation of Stock Options
Glenmark Pharmaceuticals Ltd has informed BSE that the Nomination and Remuneration Committee of the Company, at its meeting held on January 28, 2016 has cancelled 34,500 stock options pursuant to ESOS 2003.28-01-2016
Authorised KMPs to determine materiality of events/information
Glenmark Pharmaceuticals Ltd has informed BSE regarding "Authorised Key Managerial Personnel to determine materiality of events/information".28-01-2016
Announces Q3 results, Limited Review Report, Results Press Release & Management Discussion and Analysis for the Quarter ended December 31, 2015
Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended December 31, 2015:The Unaudited Standalone results for the Quarter ended December 31, 2015 (Indian GAAP)The Company has posted a net profit of Rs. 2587.58 million for the quarter ended December 31, 2015 where as the same was at Rs. 1167.30 million for the quarter ended December 31, 2014. Total Income is Rs. 13913.52 million for the quarter ended...28-01-2016
Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Glenmark Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015.25-01-2016
Shareholding for the Period Ended December 31, 2015
Glenmark Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here25-01-2016